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Abstract
Recently, there has been an increased interest in imaging different pulmonary disorders using PET
techniques. Previous work has shown, for static PET/CT, that air content in the lung influences
reconstructed image values and that it is vital to correct for this 'tissue fraction effect' (TFE). In this paper,
we extend this work to include the blood component and also investigate the TFE in dynamic imaging. CT
imaging and PET kinetic modelling are used to determine fractional air and blood voxel volumes in six
patients with idiopathic pulmonary fibrosis. These values are used to illustrate best and worst case
scenarios when interpreting images without correcting for the TFE. In addition, the fractional volumes
were used to determine correction factors for the SUV and the kinetic parameters. These were then
applied to the patient images. The kinetic parameters K1 and Ki along with the static parameter SUV were
all found to be affected by the TFE with both air and blood providing a significant contribution to the
errors. Without corrections, errors range from 34-80% in the best case and 29-96% in the worst case. In
the patient data, without correcting for the TFE, regions of high density (fibrosis) appeared to have a
higher uptake than lower density (normal appearing tissue), however this was reversed after air and blood
correction. The proposed correction methods are vital for quantitative and relative accuracy. Without
these corrections, images may be misinterpreted.
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Abstract

Recently, there has been an increased interest in imaging different pulmonary
disorders using PET techniques. Previous work has shown, for static PET/
CT, that air content in the lung influences reconstructed image values and
that it is vital to correct for this ‘tissue fraction effect’ (TFE). In this paper,
we extend this work to include the blood component and also investigate
the TFE in dynamic imaging. CT imaging and PET kinetic modelling are
used to determine fractional air and blood voxel volumes in six patients with
idiopathic pulmonary fibrosis. These values are used to illustrate best and
worst case scenarios when interpreting images without correcting for the TFE.
In addition, the fractional volumes were used to determine correction factors
for the SUV and the kinetic parameters. These were then applied to the patient
images. The kinetic parameters K1 and Ki along with the static parameter SUV
were all found to be affected by the TFE with both air and blood providing a
significant contribution to the errors. Without corrections, errors range from
34–80% in the best case and 29–96% in the worst case. In the patient data,
without correcting for the TFE, regions of high density (fibrosis) appeared to
have a higher uptake than lower density (normal appearing tissue), however
this was reversed after air and blood correction. The proposed correction
Content from this work may be used under the terms of the Creative Commons
Attribution 3.0 licence. Any further distribution of this work must maintain attribution
to the author(s) and the title of the work, journal citation and DOI.
0031-9155/15/187387+16$33.00 © 2015 Institute of Physics and Engineering in Medicine Printed in the UK
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methods are vital for quantitative and relative accuracy. Without these
corrections, images may be misinterpreted.
Keywords: lung, PET/CT, tissue fraction correction, 18F-FDG, idiopathic
pulmonary fibrosis
(Some figures may appear in colour only in the online journal)
1. Introduction
Recently whole lung PET/CT imaging has become a popular methodology for studying a
variety of inflammatory, infectious, obstructive and fibrotic pulmonary diseases (Groves et al
2009, Inoue et al 2009, Win et al 2012, Abdulla et al 2014). Imaging the lung is known to be
difficult due to respiratory motion and this has been extensively explored within the literature
(Nehmeh and Erdi 2008, Sun and Mok 2012). However little attention has been given to the
tissue fraction effect (TFE).
The TFE, a component of the partial volume effect, is the result of the finite size of an
image voxel. In the lung, the average size of an alveolus is approximately 0.008 mm3(Ochs
et al 2004), 6000 times smaller than the typical PET voxel. Consequently, a single voxel will
contain air and multiple tissue components including blood and parenchyma. The resulting
voxel value will then be an average of the tracer concentrations within that voxel and not the
signal from the parenchyma alone as required.
The importance of correcting for the air component in the lung in PET/CT SUV studies
has already been presented for patients with idiopathic pulmonary fibrosis (IPF) (Lambrou
et al 2011, Win et al 2012, 2014). This fatal restrictive fibrotic disease is characterized by an
increase in lung scar tissue which distorts the normal parenchyma architecture resulting in
regions of dense tissue with large air pockets (Meltzer and Noble 2008). In this patient group
an increase in 18F-FDG uptake was seen in regions of fibrosis in comparison to normal appearing lung regions (Groves et al 2009). As there is a greater tissue component in the fibrotic
regions, consideration was given to the TFE. By taking into account the lung air content, it was
shown that the uptake distribution actually appeared uniform throughout the lung (Lambrou
et al 2011, Win et al 2012, 2014). Correcting for the air component therefore alters image
interpretation.
Another contribution to the TFE, the blood, has not been explored yet in the literature.
Blood is a large component of the lung voxel (∼20%) (Wollmer et al 1984) and adds to the
PET signal. It therefore affects voxel concentration and must be accounted for. There are
many published methods for determining blood volume within the lung including indicator
dilution (Dock et al 1961), radiocardiographic techniques (Lewis et al 1970), cardiovascular
magnetic resonance (Ugander et al 2009, Kanski et al 2013) and dual energy CT acquisitions
(Fuld et al 2013). Unfortunately, these techniques are either invasive, use contrast agents not
suitable for all patients and/or result in whole lung blood volume estimates and not regional
or local values. An alternative method, which is utilised in this paper, is to use dynamic PET
acquisitions to estimate blood volume at a voxel level (Gunn et al 2002).
As PET/CT imaging of whole lung diseases is still poorly understood, dynamic analysis is
also being used to explore tracer and drug kinetics (Jones et al 1998, Chen and Schuster 2006,
Schroeder et al 2008, De Prost et al 2010, Schroeder et al 2011, Dittrich et al 2012). However,
to date the influence of the TFE on the kinetic parameters has not been studied.
In this paper we develop methods for correcting for the TFE in both static SUV studies
and kinetic analysis. We investigate the possible parameter estimate errors if the air and blood
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components of the TFE are not accounted for. Finally, we apply these corrections to patient
data to determine the significance of correcting for air and blood.
2. Theory
2.1. Air fraction correction in static imaging

Lung voxel air fraction correction (AFC) was first discussed by Lambrou et al (2011). In their
paper, Lambrou et al assume that a lung voxel contains only two components, air and tissue,
where tissue is the combination of both parenchyma (the non-blood cellular and extra cellular
components that make up the lung) and blood. Under this assumption, the Hounsfield Units
(HU) within a CT voxel can be considered as
HU
(1)
l = Va HUa + Vt HUt

where HUl, HUa and HUt are the HU of the lung voxel (CT voxel value), air and tissue respectively and Va and Vt are the fractional air and tissue volumes in the voxel respectively, where
Va + Vt = 1. Therefore, once the CT has been filtered to the resolution of the PET image and
downsampled, the PET voxel fractional air volume can be determined from simple rearrangement of equation (1):
HUl − HUt
V
.
a=
(2)
HUa − HUt

The PET concentration can then be corrected using equation (3):
Cmeasured
C
.
t =
(3)
1 − Va

Where Cmeasured is the measured (non-corrected) tracer concentration and Ct is the tracer
concentration in tissue after AFC. Once the AFC has been applied, the corrected voxel values
are those that would have been present without the air component (i.e. just blood and parenchyma). However, to obtain an accurate parenchyma fraction, as is required, a further correction for blood is needed.
2.2. Blood fraction correction in static imaging

Equation (1) can be expanded to include the blood component as follows:
HU
l = Va HUa + Vb HUb + Vpa HUpa
(4)

where HUb and HUpa represent the HU of blood and parenchyma respectively (which are
approximately equivalent (Hounsfield 1980)) and Vb and Vpa are the fractional blood and
parenchyma volumes in the voxel respectively.
Image concentration can be corrected for the parenchyma fraction as before with Vpa (where
Vpa = 1 − Va − Vb) replacing 1 − Va in equation (3). However, the significant amount of blood
in the lung voxel also makes it vital to correct for any PET signal that may originate from
blood. Therefore the complete correction for the concentration becomes:
Cmeasured − Vb Cb
C
− Vb Cb
C
= measured
pa =
(5)
Vpa
1 − Va − Vb

where Cb is the blood concentration, determined from an aorta or ventricle region of interest
(ROI). In this paper we demonstrate that equation (5) is far more appropriate than equation (3)
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for comparing between patients and between patients and controls. The difficulty is that the
static PET/CT does not provide information on Vb, unlike Va which can easily be calculated
from the CT image. However, Vb can be estimated directly from kinetic analysis if it is included
in the model fit (section 3.4).
2.3. Correcting kinetic parameters for the TFE

Standard kinetic modelling methods are formulated assuming that the voxel or ROI contains only
parenchyma and blood, i.e. Vb + Vpa = 1. The voxel concentration can then be assumed to be:
C
v = VbCb + (1 − Vb )Cpa
(6)

where Cv, Cb and Cpa are the activity concentrations in the voxel (or ROI), blood and parenchyma respectively. Equation (6) allows the simultaneous fit of Vb and the kinetic parameters
of the chosen model for Cpa (Tsoumpas and Thielemans 2009). Now, consider the lung case
where air is present such that Vb + Vpa ≠ 1 but Vb + Vpa + Va = 1, then the appropriate air and
blood corrected (ABC) model would be:
C
v = VbCb + (1 − Vb − Va )Cpa + VaCa
(7)

where Ca is the tracer concentration in air. Ca will be zero unless the tracer has been administered using the inhalation method.
To correctly determine the kinetic parameters, one of three methods can be utilised: (1) use
a model that follows general equation (6) and then correct the estimated parameters affected
by the TFE by multiplication of (1 − Vb )/(1 − Vb − Va ), (2) directly fit a kinetic model to the
measured data using equation (7), (3) precorrect the dynamic images for Va (as in section 2.1)
and then fit the data as follows:
C
(8)
v′ = Vb′Cb + (1 − Vb′ )Cpa

where Cv′ = Cv /(1 − Va ) and
Vb
V
(9)
b′ =
1 − Va

which is the blood volume as a fraction of the tissue.
To determine which of the estimated kinetic parameters will change after the corrections
to equation (6) have been applied, consider the corrected general equation for a compartment
model (Gunn et al 2002):
n

−θit
C
⊗ C p (t )
(10)
v′(t ) = Vb′Cb(t ) + (1 − Vb′ ) ∑ ϕi e
i=1

where, n is the number of compartments in the model, θi is the clearance from compartment i,
ϕi the applied weighting and Cp the concentration in the plasma. From this equation it can be
n
seen that it is the ϕi parameters that will be affected by the TFE. As K1 = ∑i = 1 ϕi, the delivery
of the tracer to the tissue, it is only K1 and any parameter containing K1 (e.g. the influx rate
constant (Ki)) that will require corrections.
As Ki is affected by the TFE, all of the above theory is also applicable to Patlak analysis
(Patlak et al 1983) where the corrected curve equation would be:
t

∫ Cp(t )dt
Cv′ − Vb′Cb
(11)
= Ki 0
+D
Cp(1 − Vb′)
Cp
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Table 1. Patient acquisition protocol.

Time post injection
0 min
0 min
20 min
30 min
35 min

Acquisition
Cine CT (1 PET bed) cine duration 4.5–6 s depending on respiratory rate
Patient injection
20 min dynamic PET (1 bed) 6 × 10 s, 3 × 20 s, 3 × 60 s, 5 × 120 s, 1 × 300 s
Patient break (free to move)
Cine CT (1 PET bed) cine duration same as in previous acquisition
20 min dynamic PET (1 bed) 4 × 300 s

where D is the intercept of the tissue fraction corrected Patlak curve. Unfortunately, as is the
case with static image analysis, equation (11) requires knowledge of Vb′, a parameter not normally determined during Patlak analysis. However, Vb′ can be determined from the early part
of the time activity curve (TAC), see section 3.4.
3. Methods
3.1. Patient data acquisition

Six patients, three males and three females aged 70 ± 5 yrs all with diagnosed IPF underwent 18F-FDG dynamic PET/CT using a GE Discovery VCT PET/CT scanner (Teras et al
2007). All patients were imaged supine immediately post-injection using 200 ± 26 MBq
18
F-FDG with the protocol outlined in table 1. Cine-CT imaging was acquired with a duration
equivalent to the patients complete breathing cycle plus one second. Five of the six patient
scans were obtained from an ongoing study (NCT01725139) designed to explore a number of
doses of GSK2126458 for engagement of pharmacology in subjects with IPF after short term
dosing. The remaining patient’s scan was part of an ongoing study (MREC 06/Q0505/22)
designed to explore the prognostic value of PET/CT in patients with interstitial lung disease.
Institutional Review Board permission and informed patient consent were obtained for both
studies and MHRA approval was obtained for study NCT1725139.
3.2. Simulations—kinetic analysis

To investigate the errors associated with not accounting for air and blood within a voxel, four simulated TACs were created based on real patient parameters. These TACs were constructed to represent best and worst case scenarios for investigating the difference between normal and fibrotic
regions. A best case scenario is where the difference in the fraction of parenchyma in the fibrotic
and normal appearing tissue is as low as possible. This would give rise to similar PET voxel signals in both cases and would occur when the normal appearing regions have the lowest possible
blood and air fractions (greatest possible parenchyma fraction) and the fibrotic regions have the
highest air and blood fractions. Conversely, the worst case scenario is where the difference in the
fibrotic and normal appearing tissue parenchyma fractions is high. Under these circumstances, the
average PET voxel values in each region would appear to have the greatest contrast.
To achieve realistic values for the four TAC simulations, we used results obtained from
patient analysis (section 3.4). Va and Vb were calculated for all six patients to determine the
highest and lowest air and blood fractions in the fibrotic and normal appearing regions (see
table 2). An example patient derived input function (IF) was also determined. Additionally a
set of kinetic parameters (K1, k2 and k3) from a single patient were estimated for the whole
lung TAC using the recommended FDG kinetic model, the 2 tissue irreversible compartment
model (2-ICM) (Sokoloff et al 1977).
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Table 2. Patient derived air, blood and parenchyma fractions in fibrotic and normal

appearing regions for the best and worst case scenarios.

Best case ‘Fibrotic’
Best case ‘Normal’
Worst case ‘Fibrotic’
Worst case ‘Normal’

Air fraction
Va

Blood fraction
Vb

Parenchyma fraction
Vpa

0.43
0.66
0.37
0.75

0.18
0.14
0.15
0.19

0.39
0.20
0.48
0.06

Having estimated a patient’s whole lung kinetic parameters, the four simulated noise free
TACs were created where only the air and blood fractions were varied using:
TAC
(t ) = Vb IF(t ) + (1 − Va − Vb )TrueCurve(t )
(12)

where TrueCurve is the simulated parenchyma response using the 2-ICM with the known
patient derived kinetic parameters.
For each TAC the kinetic parameters were estimated using the 2-ICM and with Patlak
analysis. The percentage difference between the true and estimated parameters with no corrections (NC), blood fraction correction (BFC) only and AFC only were determined in order
to calculate the errors caused by not applying the full ABC correction method. The percentage difference between parameters determined in the normal and fibrotic regions were also
calculated in each case as may be considered when only relative and not absolute comparison
is required.
3.3. Simulations—SUV

The standardised uptake value (SUV) is the most common parameter used in the clinical setting (Thie 2004). It is a measure of concentration normalised to the injected activity (A) and
the patients weight (W ):
C
SUV
= v
(13)
A /W

Errors in SUV associated with not accounting for air and blood within a voxel were investigated. As in section 3.2, best and worst cases were created. In addition, two patient representations were determined (based on the data from the six patients), each with different blood
tracer concentrations. This is because SUV, unlike the kinetic parameters, is affected by the
concentration in blood as well as the Vb, introducing a further source of error specific to comparisons between patients and between patients and controls.
For the simulations, the final time point of the TrueCurve derived in section 3.2 was used to
represent the true whole lung parenchyma concentration (and hence SUV) in a static image.
The best and worst case concentrations for the fibrotic and normal appearing regions were
achieved by applying the simple re-arrangement of equation (5) and using the Va and Vb values
in table 2. For the concentration in blood, the mean and standard deviation of the aorta concentrations at the final time point for all six patients was determined. The two Cb values used
were the mean ±1 standard deviation.
To determine the maximum and minimum errors that may be expected if the full ABC correction is not applied, the percentage differences between the NC, BFC and AFC and the true
parenchyma concentration, between the values determined from the different blood concentrations and between fibrotic and normal appearing tissues were calculated.
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3.4. Patient analysis

PET images were reconstructed using FBP with an average of the Cine-CT acquisition for
attenuation correction. The average Cine-CT was used to minimise any CT-PET mismatch
due to respiratory motion (Pan et al 2005). As the patients were allowed to move between
the two study sections, the two average Cine-CT images were registered using a non-rigid
technique with the NiftyReg software (Ourselin et al 2001, Modat et al 2010) and the transformation fields applied to the appropriate PET images. The PET images then underwent
AFC with the correction factors derived from the average Cine-CT as described in section 2.1.
The concentration of activity in blood at each time point was determined using a 3D ROI
drawn manually on the aorta. The aorta was identified on fused PET and CT (using early PET
frames). A previously defined model (Sari et al 2014) was then used to fit these data points to
produce an input function (IF).
Vb was determined on a voxel basis using the first minute of the initial dynamic acquisition.
High voxel TAC noise rendered full compartment modelling impractical with poor fit stability
even after image smoothing. Vb was therefore considered as the scaling factor between the TAC
and the IF allowing a model fitting Vb and time delay (between the TAC and IF) to be used. With
image smoothing using a Gaussian filter with a 12 mm FWHM, this method resulted in fast
processing with high stability. To calculate Vb′, the same method was adopted with AFC applied
to the images prior to smoothing to ensure correct match between PET and CT.
For each patient, the average cine-CT was used to segment the lungs using a thresholding technique to create a whole lung mask (WLMask). The fractional parenchyma volume
maps were reviewed and any voxels with a value of  <5% were removed from the WLMask to
ensure voxels containing mostly air (e.g. bullae) or mostly blood (i.e. blood vessels) were not
analysed. Regions within this WLMask were then further segmented to separate regions of
higher density (HDMask) representative of fibrosis and lower density (LDMask) representative of normal appearing tissue. For each patient, SUV and voxel based Patlak analysis were
applied to the regions within each of the HD and LD masks. AFC and ABC were applied to
the patients as described in section 2 and the masks were used to compare average regional
results before and after corrections. In all cases, kinetic analysis was performed using in-house
validated software.
4. Results
4.1. Simulations—kinetic analysis

Table 3 displays the results of ignoring the TFE for the worst and best case scenarios. The
‘True’ values represent the correct parameters after ABC (i.e. with no air or blood present).
The results confirm that the only parameters affected by the TFE are K1 and Ki both in the case
of 2-ICM and Patlak analysis. The TFE causes the affected kinetic parameters to be underestimated and this error reduces with BFC and AFC. It can also be seen that the determined Vb is
not affected by the presence of air (table 2).
Table 4 lists the percentage differences between the true and calculated Ki after each correction. The TFE causes the affected kinetic parameters to be underestimated by 96–52%
without any corrections and this error reduces with both BFC and AFC.
Table 5 is a comparison between the normal and fibrotic regions in each case. As the TACs
were all determined from the same parameters, then the true Ki should be identical in all cases.
As can be seen, not correcting for the presence of air and blood results in a significant error
with Ki appearing between 49% and 92% different.
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Table 3. Determined kinetic parameters with no corrections applied.

True

K1

K2

K3

Ki2

KiP

Vb

0.17

0.51

0.0203

0.0065

0.0065

*

0.07
0.03

0.51
0.51

0.0203
0.0203

0.0025
0.0013

0.0025
0.0013

0.18
0.14

0.08
0.01

0.51
0.51

0.0203
0.0203

0.0031
0.0003

0.0031
0.0003

0.15
0.19

Best case
Fibrosis
Normal
Worst case
Fibrosis
Normal
*

See table 2 for the true Vb for each case.
Ki2 = influx rate determined from the 2-ICM.
KiP = influx rate determined from Patlak analysis.
Note these two methods should (and do) produce the same result.
Table 4. Percentage difference between the true and measured Ki before and after
blood or air corrections.

NC

BFC

AFC

−61%
−80%

−52%
−77%

−32%
−41%

−52%
−96%

−44%
−95%

−24%
−83%

Best case
Fibrosis
Normal
Worst case
Fibrosis
Normal
NC = No Correction,
BC = Ki /(1 − Vb ),
AFC = Ki /(1 − Va ).
Table 5. Percentage difference between Ki in the two regions (normal/fibrotic) in each

case before and after blood or air corrections.

Best case
Worst case

NC

BFC

AFC

−49%
−92%

−51%
−91%

−14%
−77%

4.2. Simulations—SUV

The average whole lung parenchyma concentration in a static image, as determined from the
simulated ABC TAC, was found to be 3.4 kBq ml−1. The mean blood concentration for the
six patients was found to be 3.9 ± 1.2 kBq ml−1 therefore the blood concentrations used to
represent two patients were Cb1 = 5.1 kBq ml−1 and Cb2 = 2.8 kBq ml−1.
Table 6 lists the concentrations and their percentage differences (in brackets) from the true
result in each case, with and without corrections. As can be seen, if the correction for blood
fraction is applied without correcting for air, then the parameter estimate accuracy is decreased
in comparison to no correction at all. As with the kinetic parameters, all concentrations are
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Table 6. Determined average parenchyma static concentrations before and after
corrections for each region and case and their percentage difference to the true
concentration, 3.4 kBq ml−1.

NC

BFC

AFC

Cb1

Cb2

Cb1

Cb2

Cb1

Cb2

2248
(−34%)
1397
(−59%)

1827
(−46%)
1070
(−69%)

1328
(−61%)
681
(−80%)

1328
(−61%)
681
(−80%)

3944
(−16%)
4108
(−21%)

3206
(−6%)
3146
(−8%)

2401
(−29%)
1108
(−67%)

2050
(−40%)
664
(−81%)

1634
(−52%)
136
(−96%)

1634
(−52%)
136
(−96%)

3811
(12%)
4816
(41%)

3255
(−4%)
2886
(−15%)

Best Case
Fibrosis
Normal
Worst Case
Fibrosis
Normal

Note: Cb1 and Cb2 are the blood concentrations and are equal to 5.1 kBq ml−1 and 2.8 kBq ml−1
respectively.
Table 7. Percentage difference between measured concentrations in the two regions

(normal/fibrotic) in each case before and after corrections.
NC

Best Case
Worst Case

Cb1
−38%
−54%

BFC
Cb2
−41%
−68%

Cb1
−49%
−92%

AFC
Cb2
−49%
−92%

Cb1
4%
26%

Cb2
−2%
−11%

underestimated with an error range of 81% to 29% when no corrections have been applied.
After AFC this error still ranges from  −4% to 41%. AFC without BFC can also be seen to
overestimate the concentration when Cb is greater than the concentration in the parenchyma.
Complete correction is only obtained after ABC.
The percentage difference between the two patient simulations was found to range between
17% and 67% without any corrections. As the only variation is the blood concentration, BFC
alone causes the concentrations in both patients to be equal in each case (although underestimated by up to 96% due to the presence of air).
Table 7 is the percentage difference between the normal and fibrotic regions for a relative
comparison. In the best case situation, after AFC, the concentrations are within 5% and therefore could be considered as approximately equivalent, however, this is not true for the worst
case scenario where the difference is still as high as 26%.
4.3. Patient analysis

Figure 1 displays the fibrotic (HD) and normal appearing (LD) Patlak derived influx rate
constant (KiP) for the NC, AFC and ABC cases for all six patients. It can be seen that in
all patients the HD regions have a higher KiP than that of the LD region in the NC case
( p   =   0.01). After AFC, the regions become comparable with a p value of 0.35 and after
ABC, the LD regions are significantly increased with respect to the HD regions ( p   =   0.01).
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Figure 1. Bar graphs displaying the difference in Ki in fibrotic (light grey bars) and

normal (dark grey bars) appearing regions determined from the mean of the HDMask
and LDMask (with  >5% fractional parenchyma volume threshold) over the Ki Patlak
parametric images for all analysed patients. In the top chart, no corrections have been
applied, the middle chart displays the values following AFC and the bottom chart is
after ABC. Note that the influx rate appears higher in fibrotic regions when compared to
the normal appearing regions without corrections but lower after correction.

Figure 2 is the SUV equivalent to figure 1 where it can be seen that the trend is similar to the
KiP case with the HD regions appearing significantly higher than the LD regions in the NC
case ( p   =   0.0001), approximately equivalent after AFC ( p   =   0.092) and significantly lower
in the ABC case ( p   =   0.0001).
Figure 3 displays an example parametric KiP image for each correction method. In the top
left (a) the CT image can be seen displaying obvious regions of fibrosis (white arrows) and a
region of normal appearing tissue (black arrow). In the top right (b) is the parametric image
with no corrections displaying an apparent high influx rate in regions of fibrosis in comparison
to those of normal appearance. In the bottom left (c) is the AFC image where the influx rate
appears more uniform throughout the lung and after ABC (d) the regions of fibrosis appear to
have a lower influx rate than those of normal appearance. Figure 4 displays the SUV results
in the same layout as figure 3.
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Figure 2. Bar graphs displaying the difference in SUV in fibrotic (light grey bars) and
normal appearing regions (dark grey bars) determined from the mean of the HDMask
and LDMask (with  >5% fractional parenchyma volume threshold) over the final
dynamic PET frame for all analysed patients. In the top chart, no corrections have been
applied, the middle chart displays the values following AFC and the bottom chart is
after ABC. Note that the SUV appears higher in fibrotic regions when compared to the
normal appearing regions without corrections but lower after correction.

5. Discussion
Air and blood are significant components of the lung and have a considerable effect on the
measured PET voxel tracer concentration. The result of not accounting for these components
is a significant underestimation of the parenchyma signal. Moreover, the extent of this error is
dependent on the highly variable voxel blood and air fractions throughout the lung.
Fractional air volume in static imaging has been previously discussed (Lambrou et al 2011)
where it was shown, in agreement with the results found here, that SUV within the IPF lung
appears more uniform after AFC. Lambrou et al were the first to note that the air component
can lead to inaccurate parameter estimates and misinterpretation of results in SUV imaging
and this is especially true when comparing between different lung density regions in a single
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Figure 3. Patlak Ki parametric images from an example patient. Image (a) is the CT

displaying regions of obvious fibrosis (white arrows) and a region of normal appearing
tissue (black arrow). Image (b) is the uncorrected parametric image, image (c) is the
same image after AFC and image (d) after ABC. All images have been normalised such
that they can be shown on the same arbitrary grey scale. All images are shown after
whole lung masking with  >5% fractional parenchyma volume thresholding.

patient, between patients and/or between patients and controls. Here this methodology has
been expanded to include blood correction in both static and dynamic analysis.
Table 6 highlights the need for correcting for air fraction in static imaging where the error
after AFC can be seen to reduce from 81% to 41% in the worst case and 29% to 4% in the best
case. However, AFC may over or under correct the concentration depending on whether the
Cb is greater or lower than Cpa respectively. This indicates that for static imaging, using AFC
alone is not sufficient for comparison between patients.
Kinahan and Fletcher (2010) found SUV test-retest variability to be as high as ±20%,
therefore here we consider this as the upper limit of acceptable error. When comparing different regions in a single patient with high Cb (table 6), it can be seen that after AFC, only in the
fibrotic regions are the results below this limit. When considering relative change between the
different density regions (table 7), only in the best case scenario can the HD and LD regions be
considered comparable. AFC alone is therefore not enough for accurate image interpretation
within a single patient and ABC is vital.
ABC is important as the blood volume as a fraction of tissue can be as high as 75% in normal appearing regions and 32% in the presence of fibrosis. This high blood volume is also the
cause of the change in SUV error when two different blood concentrations are applied with no
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Figure 4. Example SUV images from a single patient. Image (a) is the CT as in
figure 3(a). Image (b) is the uncorrected SUV image (grey scale 0–1.5 SUV), image
(c) is the same image after AFC (grey scale 0–3.5 SUV) and image (d) after ABC (grey
scale 0–12 SUV). All images are shown after whole lung masking with  >5% fractional
parenchyma volume thresholding.

other alterations to the two static simulations (tables 6 and 7). As blood concentration would
not be the only difference between patients, these results are best case limits.
Vb cannot be ascertained for static imaging using current clinical protocols and therefore
ABC cannot be applied. However Vb can be determined from a one minute dynamic acquisition immediately after injection. The addition of this short dynamic to the imaging protocol
could reduce the error in the calculated concentration by 81%, significantly improving image
interpretation (table 6).
The characterisation of systematic errors associated with not performing ABC was achieved
with use of noise free TACs. In this work we have not compared this bias with the random
errors due to noise in the data. An investigation into error propagation due to noise in the correction factors is left for future work.
Although AFC is only required for the lung, BFC can be applied throughout the body. BFC
is not commonly utilised in areas such as the brain or oncology ether due to the necessity of
dynamic imaging to obtain Vb or because Vb is regularly considered negligible. However, BFC
is vital in regions in which the blood volume is high, variable across the ROI, or where uptake
within the blood is high with respect to that of the tissue of interest, all of which are true in
the lung case.
In this paper we have used a voxel-wise method for correcting for the TFE. This method
is limited by the accuracy of the PET/CT registration and resolution matching, a difficult
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problem in the lung. In addition, in voxels that contain low parenchyma fractions, such as in
airways, bullae and blood vessels, the corrected values will be sensitive to noise and errors in
the estimated Va and Vb. We have addressed these problems by using averaged Cine-CT data to
match the PET as closely as possible, and by excluding voxels with Vpa < 5% from the analysis. Alternatively, a method using average correction factors for a ROI could be used. This is
advantageous for regions with uniform PET tracer delivery and uptake kinetics. However, the
time for the PET tracer to reach different parts of the lung is known to be variable. Moreover,
it is possible that in the IPF lung, kinetic parameters may vary between different voxels.
Therefore, a voxel-wise analysis was judged more appropriate. For the patient data, we have
presented results using Patlak analysis as compartmental modelling was unstable at the voxel
level due to noise.
Patient data were reconstructed using FBP techniques. This analytical method was used to
avoid issues with quantification when using iterative reconstruction methods, e.g. due to variable convergence rates and bias in regions of low radiotracer concentration such as the lung.
The tissue fraction correction methodology described in this work was applied to patients
with IPF. However, it is applicable to imaging of all pulmonary diseases and any organ in
which air or large fractional blood volumes are present. ABC removes bias due to variations
in the quantity and uptake of the air and blood components, ensuring that the measured PET
signal originates from the parenchyma only. However, it is noted that parenchyma may be
heterogeneous, especially when comparing between the normal appearing and fibrotic regions
of the lung. Therefore, the use of further corrections may need to be investigated.
Application of the tissue fraction correction to the IPF patients displays an inversion of
initial results. Without correction, it appears that the fibrotic regions have a higher uptake
(SUV) and influx rate (KiP) than that of the normal appearing regions in the IPF lung. After
AFC, both regions appear equivalent in SUV and KiP, but after ABC, it is the normal appearing
regions that have increased parameter estimates and this is consistent between all patients. The
interpretation of these results would therefore differ depending on which (if any) correction
method was used.
The observation of increased tracer uptake in the normal appearing regions with respect to
that of the fibrotic regions is a relative result. Further work is therefore required to determine
how the different regions may compare to those of a control lung. Win et al (2014) compared normal regions in IPF patients to controls and found, after AFC only, that the normal
IPF regions have an increased uptake with respect to the controls. However, here it has been
shown that a 67% difference can be found in two patient groups with the same parenchyma
concentration but with different blood concentrations. Therefore, the results of Win et al need
confirmation by taking the blood component of the TFE into account.
6. Conclusion
Methods for correcting for the air and blood components in a lung voxel have been described
for SUV and dynamic analysis. These methods are an extension of previously published work
which used CT to account for differences in air fraction in static imaging. We have used a short
dynamic scan to determine blood fraction and demonstrated that in the lung, the combination
of air and blood fraction correction is essential for obtaining accurate parameter estimates in
both dynamic and static imaging. Application of these corrections in patients with IPF has
been shown to change the interpretation of results and to be vital for comparisons between
different density regions in a single patient, between patients and/or between patients and
controls.
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